Virus Trial Ends For Malaria Drug

AP News
July 04, 2020 - 7:38 pm
Doctor holding Hydroxychloroquine drug

BartekSzewczyk / iStock / Getty Images Plus


By Associated Press


(AP) - The World Health Organization says it is ending a trial on whether anti-malaria drug hydroxychloroquine helps patients hospitalized with COVID-19.

WHO said Saturday it accepted the recommendation from the committee overseeing the trial to discontinue testing of hydroxychloroquine and lopinavir/ritonavir, a drug combination used to treat HIV.

The drugs were being compared with standard care for hospitalized patients.

WHO says a review of the interim results show hydroxychloroquine and lopinavir/ritonavir “produce little or no reduction in the mortality of hospitalized COVID-19 patients.”

The agency adds that there was no “solid evidence” of increased mortality for hospitalized patients given the drugs.